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Edited by Frances ShannonAbstract Lysine-speciﬁc histone demethylase 1 (LSD1) is a
very recently discovered enzyme which speciﬁcally removes
methyl groups from Lys4 of histone 3. We have addressed the
functional properties of the protein demonstrating that histone
demethylation involves the ﬂavin-catalysed oxidation of the
methylated lysine. The nature of the substrate that acts as the
electron acceptor required to complete the catalytic cycle was
investigated. LSD1 converts oxygen to hydrogen peroxide
although this reactivity is not as pronounced as that of other ﬂa-
vin-dependent oxidases. Our ﬁndings raise the possibility that in
vivo LSD1 might not necessarily function as an oxidase, but it
might use alternative electron acceptors.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Histones are substrates for a number of covalent modiﬁca-
tions that control chromatin state and gene expression. Meth-
ylation of lysine residues on the N-terminal tails of histones is
one of the elements that deﬁne the so-called ‘‘histone code’’ [1].
Very recently, Shi et al. [2] have described the discovery of
lysine-speciﬁc histone demethylase 1 (LSD1), an enzyme which
has remained elusive for decades and whose existence has even
been questioned. This protein was shown to act on dimethy-
lated Lys4 of histone 3 (H3-K4). The LSD1-catalysed reaction
regenerates the methyl-free lysine together with release of
formaldehyde (Fig. 1, [2]). LSD1 comprises an N-terminal
SWIRM domain and a C-terminal ﬂavin domain which shows
homology to members of the amine oxidase family (Fig. 2).
These enzymes catalyse the oxidative deamination of com-
pounds that contain primary, secondary or tertiary aminesAbbreviations: LSD, lysine-speciﬁc histone demethylase; D184, human
LSD1 mutant harbouring a deletion of the N-terminal 184 amino
acids; D157, mutant harbouring a deletion of the N-terminal 157
amino acids; H3-K4, Lys4 of histone 3; H3-K9, Lys9 of histone 3
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doi:10.1016/j.febslet.2005.03.015[3]. LSD1 (also known as KIAA0601) has been typically found
in association with CoREST and histone deacetylases 1 and 2
[4,5]. These proteins form a highly conserved module [6–8] that
has been shown to be part of several megadalton co-repressor
complexes, which are proposed to operate in the context of a
stable and extended form of repression through silencing of en-
tire chromatin domains [9,10].
Here, we report on the production, puriﬁcation of two LSD1
truncated forms, lacking the ﬁrst 157 (D157) and 184 (D184)
amino acids (Fig. 2), respectively, and we demonstrate that:
(i) the C-terminal 702 residues of the protein contain the fully
functional histone demethylation site; (ii) histone demethyla-
tion involves the enzyme-bound FAD cofactor; (iii) the protein
exhibits oxidase activity but it can function also with a syn-
thetic mono-electronic acceptor, raising the hypothesis that
in vivo enzyme reoxidation might not be an oxygen-mediated
process and it can involve alternative electron acceptors.2. Methods
2.1. Protein expression and puriﬁcation
All chemicals were purchased from Sigma–Aldrich unless speciﬁed.
Analysis of the amino acid sequence (Fig. 2) with bioinformatics tools
[11] predicts that the N-terminal 150 amino acids lack secondary struc-
tures. We produced two mutant proteins that lack the ﬁrst 157 (D157)
and 184 (D184) amino acids. The cDNA obtained by PCR coding for
mutant harbouring a deletion of the N-terminal 157 amino acids
(D157) and human LSD1 mutant harbouring a deletion of the N-termi-
nal 184 amino acids (D184) mutants were sub-cloned into a pET28b
vector and expressed in Escherichia coli cells (BL21-DE3). Cells were
grown in a 5 l Bioﬂo 3000 fermentor at 37 C up to OD600 of 0.9, tem-
perature was lowered to 25 C, and cells were harvested 6 h after the
addition of 0.5 mM isopropyl b-D-thiogalactopyranoside. Cells (15 g)
were resuspended in 75 ml lysis buﬀer (50 mM sodium phosphate,
pH 7.8, 5% glycerol, 200 mM NaCl, 1 mM phenyl-methylsulphonil
ﬂuoride). The suspension was passed through a French press and cell
debris was removed by centrifuging at 70 000 · g at 4 C. The superna-
tant was incubated for 3 h at 4 C with 3 ml of a 50% slurry Ni-NTA
(Qiagen) equilibrated in lysis buﬀer. The resin was poured onto a col-
umn, washed with 50 mM sodium phosphate, 300 mM NaCl, 10 mM
imidazole, 5% glycerol and the protein was eluted with 50 mM sodium
phosphate, 300 mM NaCl, 250 mM imidazole, 5% glycerol. The frac-
tions enriched in LSD1 were pooled and chromatographed on a
MonoS HR 5/5 column (Amersham) equilibrated in 50 mM sodium
malonate, pH 5.2, 200 mM NaCl, 10% glycerol. Elution was per-
formed with a 15 ml linear gradient of NaCl (200 mM–1 M). LSD1-
containing fractions were concentrated by Centricon30 centrifugal
concentrators, gel ﬁltered on a Superdex200 HR 10/30 column equili-
brated and eluted with 25 mM potassium phosphate, pH 7.2, 5%blished by Elsevier B.V. All rights reserved.
Fig. 1. Scheme of the oxidative demethylation reaction catalysed by the ﬂavin-dependent amine oxidase LSD1.
Fig. 2. Domain organisation of human LSD1. We use as reference, the sequence of human LSD1 deposited in the NCBI database under the
accession code BAA25527 (886 residues). Residue Met35 of this sequence corresponds to the ﬁrst amino acid of the protein characterised by Shi et al.
[2]. Met157 and Lys184 are the sites of N-terminal truncation in the D157 and D184 mutants. The GXGXXG sequence represents the highly
conserved motif located at the N-terminus of the ﬂavin-binding domain.
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mated to be greater than 95% homogeneous as judged by SDS–PAGE
analysis. The A280/A458 was about 10 for both mutants. Puriﬁed en-
zymes were stored on ice.
2.2. Cofactor analysis
D184 and D157 (10 lM) aliquots were incubated at 100 C in the
dark for 15 min and denatured protein was removed by centrifugation.
The spectrum of the supernatant exhibited the typical features of free
ﬂavin with an absorption peak at 450 nm (rather than 458 nm of the
LSD1-bound ﬂavin). This indicates the non-covalent nature of cofac-
tor binding. The method of Aliverti et al. [12] was employed to discrim-
inate between FAD and FMN.
2.3. Enzyme reactivity
D184 (10 lM in 25 mM potassium phosphate, pH 7.2, 5% glycerol)
was anaerobically incubated with 20 lM dimethylated H3-K4 peptide
(from Upstate Group Inc.) and spectral changes were monitored by
using a HP 8453 UV/Vis diode-array spectrophotometer. Enzyme reox-
idationwas performed by either anaerobic addition of ferriceniumhexa-
ﬂuorophosphate [13,14] or exposure to air. Ferricenium stock solutions
were standardised spectrophotometrically at 617 nm by using an extinc-
tion coeﬃcient e617 = 410 M
1 cm1. Oxygen and ferricenium reactivity
was analysed also with reference to enzyme that has been photoreduced
in the presence of 1 lM deazaﬂavin and 5 mM EDTA [15].
2.4. Activity assays
Time-course measurements were performed under aerobic condi-
tions by using a Cary 100 UV/Vis spectrophotometer. The reaction
was started by adding the protein at two diﬀerent concentrations
(0.5 and 3.1 lM in 25 mM potassium phosphate, pH 7.2, 5% glycerol
in a ﬁnal volume of 100 ll). In the peroxidase-coupled assay [16], the
mixture contained 0.1 mM 4-aminoantipyrine, 1 mM 3,5-dichloro-2-
hydroxybenzenesulfonic acid, 2.8 lM horseradish peroxidase, and
17 lM dimethylated H3-K4 peptide; absorbance changes were moni-
tored at 515 nm (e515 = 26 000 M
1 cm1). In the ferricenium assay,
the mixture contained 70 lM ferricenium hexaﬂuorophosphate and
17 lM dimethylated H3-K4 peptide. Decrease of absorbance at
300 nm was monitored (e300 = 4300 M
1 cm1 [14]).3. Results and discussion
We refer to the experiments that have been performed using
the D184 mutant; the D157 protein exhibits virtually identical
reactivity and spectroscopic properties (not shown).
3.1. LSD1 reactivity with H3-K4 dimethylated peptide
Puriﬁed LSD1 mutants were found to contain a bound ﬂavin
cofactor (Fig. 3A), which was shown to be FAD. Protein dena-
turation led to cofactor release, implying that it is not cova-
lently bound. LSD1 was anaerobically incubated with
dimethylated H3-K4 peptide (Fig. 3A) leading to the reduction
of the enzyme-bound cofactor as indicated by the bleaching of
the absorption peak at 458 nm. Reaction with the substrate re-
sulted in the accumulation of the two-electron fully reduced
ﬂavin without any detectable formation of one-electron re-
duced forms of the cofactor. These features demonstrate that
the ﬁrst step in the demethylation reaction is the ﬂavin-medi-
ated two-electron oxidation of the methylated lysine; this leads
to formation of the corresponding imine molecule coupled to
cofactor reduction (Fig. 1). To complete substrate demethyla-
tion, hydrolysis of the imine must occur. It remains to be
established whether this hydrolytic step is catalysed by the en-
zyme with release of the demethylated peptide, or hydrolysis is
a non-enzymatic process that takes place in solution after dis-
sociation of the enzyme–product complex.
3.2. LSD1 has oxidase activity
Completion of the catalytic cycle requires reoxidation of the
ﬂavin cofactor (oxidative half-reaction; Fig. 1). In this regard,
the key question concerns the nature of the physiological elec-
tron acceptor. We have probed the enzyme for its ability to re-
act with molecular oxygen. Exposure of the reduced enzyme to
Fig. 3. Reactivity of LSD1. (A) Reduction by 20 lM H3-K4
dimethylated peptide under anaerobic conditions. The experiment
was carried out using D184 mutant (10 lM). The spectral changes
in the UV/Vis range indicate the occurrence of the ﬂavin reduction.
From the bleaching of the 458 nm peak it can be estimated that
>80% of the enzyme is reduced. Spectra were measured at 0
(oxidised enzyme), 2, 2.5, 3, 7, 10, 13, 27, 55, and 152 min after
anaerobic incubation with the peptide. (B) The anaerobically
reduced enzyme (see A) was exposed to air. The oxygen reacts
with the ﬂavin leading to enzyme re-oxidation. Spectra were
measured at 0 (reduced enzyme), 1.5, 2, 2.5, 3, 5.5, and 10 min
after exposure to air. (C) Time-course of the re-oxidation process.
The curve shows the ﬁt of the data to a single exponential process
according to the following equation: Abs = 0.125  0.90 Æ e0.0.12Æt
with t expressed as seconds.
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absorption spectrum that was indistinguishable from that of
the native enzyme. Completion of the reoxidation process took
several minutes (Fig. 3C). Oxygen reactivity was also probed
using enzyme that was reduced by light exposure in the pres-
ence of deazaﬂavin and EDTA [15]. The time-course of the
oxidation reaction was essentially identical to that observed
with the substrate-reduced enzyme, indicating that oxygen
reactivity is not greatly aﬀected by the presence of the reaction
substrate or product. Demonstration that oxygen can function
as electron acceptor prompted us to check whether oxygen-
mediated ﬂavin reoxidation produces H2O2. For this purpose,
the enzyme was incubated with dimethylated H3-K4 peptide
and the production of H2O2 was monitored with a peroxi-
dase-coupled assay (Fig. 4) [16]. Taken together, these experi-
ments demonstrate that histone demethylation by LSD1 is an
oxidative process that can use oxygen as electron acceptor with
production of H2O2.
3.3. Reactivity with a synthetic electron acceptor
We investigated the reactivity of LSD1 with alternative elec-
tron acceptors to be employed as substrates in the oxidative
half-reaction (Fig. 1). Ferricenium has been often used a syn-
thetic electron acceptor to assay for the activity of ﬂavin-depen-
dent oxidoreductases [14]. Ferricenium is reduced to ferrocene
(Fig. 1) in a one-electron reaction that can be convenientlymon-
itored by UV/Vis absorption spectroscopy. Anaerobic addition
of ferricenium to reduced LSD1 led to reoxidation of the protein
(Fig. 5A). In particular, an equimolar concentration of ferrice-
nium led only to partial reoxidation, consistently with the fact
that it is a one-electron acceptor. Incubation with more than a
twofold molar excess was necessary to completely regenerate
the oxidised enzyme (Fig. 5A). An important feature in the reac-
tion is that the ferricenium-mediated oxidation of LSD1
is essentially instantaneous, clearly diﬀering from the slowerFig. 4. Demethylase activity was detected using a peroxidase-coupled
assay by measuring the increase in absorbance at 515 nm. The assay
was carried out using 17 lM H3-K4 dimethylated peptide at two
protein concentrations (0.5 and 3.1 lM; solid lines). Under these
conditions, the apparent enzyme turnover number is 1.8 min1. The
assay was performed also using 17 lMH3-K9 dimethylated peptide at
3.1 lM protein concentration (dashed line). No activity was detected
indicating that H3-K9 is not a substrate of LSD1.
Fig. 5. Reoxidation of D184 LSD1 mutant by ferricenium. (A) Spectrum of the anaerobically two-electron reduced enzyme (black; 3.0 lM). After
incubation with an equimolar concentration of ferricenium (red) the enzyme is partly reoxidised, in keeping with the fact that ferricenium is a one-
electron acceptor. Complete reoxidation is obtained only after addition of a second aliquot of ferricenium (blue) that raises its concentration to
8.5 lM. Exposure to air does not cause any further alteration of the spectrum (green) demonstrating that ferricenium is able to fully reoxidise the
enzyme. The reoxidation by ferricenium occurs very rapidly after incubation indicating fast reactivity. (B) Activity measurement using ferricenium as
electron acceptor with 17 lM H3-K4 dimethylated peptide at two protein concentrations (0.5 and 3.1 lM). Ferricenium reduction is detected by
measuring the decrease of absorbance at 300 nm. In these conditions, the apparent enzyme turnover number is 1.28 min1.
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3C).
3.4. Demethylase activity assays and reaction speciﬁcity
The described experiments suggest two convenient methods
to assay the demethylase activity of LSD1 that are based on
the ‘‘oxygen reactivity’’ and ‘‘ferricenium reactivity’’, respec-
tively. The oxidase activity of LSD1 generates H2O2, whose
formation can be detected with an enzyme-coupled assay [16]
(Fig. 4). Ferricenium has a characteristic absorption spectrum
that changes upon reduction to ferrocene. This feature com-
bined with the eﬀectiveness of ferricenium as electron acceptor
provides another convenient way to assay for demethylase
activity (Fig. 5B).Making use of these two assays, we have studied the speciﬁc-
ity of the oxidative demethylation reaction catalysed by LSD1.
In agreement with Shi et al. [2], we did not observe any activity
on peptides dimethylated at Lys9 rather than Lys4 (Fig. 4). In
addition, the enzyme did not exhibit any detectable activity in
the presence of methyllysine, trimethylamine, methylglycine,
and methylarginine. These ﬁndings imply that LSD1 is not
responsible for the activity that was measured by Kim et al.
[17] who ﬁrst reported on a demethylase acting on histones
as well as on free methyllysine. We also probed the enzyme
for the ability to oxidise compounds that are substrates of
the homologous enzymes polyamine oxidase (spermine, sper-
midine, and acetylated derivatives), putrescine oxidase (1,4-
diaminobutane), and monoamine oxidase (aromatic amines
F. Forneris et al. / FEBS Letters 579 (2005) 2203–2207 2207including benzylamine, tyramine, and amphetamine). None of
these compounds exhibited any reactivity. Likewise, we have
tested various covalent and non-covalent inhibitors of mono-
amine oxidase and polyamine oxidase [3,18] for their ability
to inhibit LSD1 activity or to act as LSD1 substrates. Also
for these molecules we could not ﬁnd any functional eﬀect.
LSD1 is very speciﬁc for H3-K4 substrate unlike other amine
oxidases such as polyamine oxidase and monoamine oxidase
that exhibit relatively broad speciﬁcities. Our ﬁndings predict
that the substrate/inhibitor-binding site of LSD1 will substan-
tially diﬀer from that of homologous amine oxidases of the ﬂa-
vin class [3].4. Conclusions
We have shown that removal of the methyl group(s) from
H3-K4 is an oxidative process: the substrate is oxidised by
FAD to generate the corresponding imine that is subsequently
hydrolysed. Thus, LSD1 behaves like a typical ﬂavoenzyme of
the oxidoreductase/oxidase class that catalyses the two-elec-
tron oxidation of its substrate. The fact that both N-terminally
truncated mutants are competent in speciﬁc histone demethyl-
ation and both tightly bind FAD indicates that the N-terminal
amino acids are not crucial for activity and cofactor binding.
They might contribute to the recruitment and binding of other
protein partners that are part of repression complexes.
An intriguing question about LSD1 function concerns the
nature of the physiological substrate which acts as electron
acceptor to complete the catalytic cycle. We have shown that
LSD1 has oxidase activity. However, generation of hydrogen
peroxide in the chromatin environment might favour oxidative
damage of DNA and might be harmful. Thus, the possibility
exists that at least under certain conditions, molecules other
than oxygen can function as electron acceptors. The fact that
oxygen reactivity is not especially pronounced (Fig. 3C) when
compared to that of other ﬂavin-dependent oxidases supports
this hypothesis.
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